APSR2026-577

Yes
Late-Breaking
Submitted
Oral Presentation
AO21-002
 
 
https://storage.unitedwebnetwork.com/files/1285/1220615-46903-APSR2026-577_440313.pptx
Format: PPTX Only
 
Format: PDF Only
06. Tuberculosis
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Nisa Aprilen * Brawijaya University Department of Pulmonology, Faculty of Medicine Brawijaya University Malang Indonesia
Yani Jane R. Sugiri - Brawijaya University Department of Pulmonology, Faculty of Medicine Brawijaya University Malang Indonesia
Ungky Agus Setyawan - Brawijaya University Department of Pulmonology, Faculty of Medicine Brawijaya University Malang Indonesia
Ani Budi Astuti - Brawijaya University Department of Statistics, Faculty of Mathematics and Natural Sciences Malang Indonesia
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Nisa
Aprilen
naprilen@gmail.com
+6282274472337
31-40
Indonesia
Original Research
Analysis of CXCL-9 Levels and Chest X-ray Findings in Drug-Sensitive Tuberculosis, Drug-Resistant Tuberculosis, and Control Group Patients
Maximum 25 words
Abstract Content
C-X-C motif chemokine ligand-9 (CXCL9) levels are a key focus in tuberculosis (TB) research for their role in immune response and as a diagnostic and prognostic biomarker. Higher CXCL-9 levels are found in drug-resistant tuberculosis (DR-TB) compared to drug-sensitive tuberculosis (DS-TB). Chest X-ray plays a vital role in detecting lung abnormalities, with DR-TB showing more severe changes. This study analyzes differences in CXCL9 levels and chest X-ray findings between DS-TB and DR-TB patients and evaluates their combined use.
This cross-sectional study analyzed CXCL9 levels and chest X-ray findings in DS-TB, DR-TB, and control groups, using regression analysis to explore their relationship. Samples were selected via purposive sampling, and data were analyzed with ANOVA, multivariate regression, and ROC/AUC to assess the ability of the CXCL9 and X-ray combination to distinguish DS-TB from DR-TB. Conducted at four hospitals in East Java, data collection involved physical exams, blood samples for CXCL9 analysis, and chest X-ray assessments to evaluate disease severity.
The highest CXCL-9 levels were found in DS-TB (192.13 pg/mL), compared to DR-TB (66.55 pg/mL) and controls (11.84 pg/mL), with a significant difference (p=0.000). Moderate CXR lesions were most common (43.2%), differing between TB and controls (p=0.000) but similar across TB types (p=0.695). A weak to moderate positive correlation was found between CXCL-9 and CXR severity (r=0.361, p=0.001). Ordinal logistic regression showed that TB history significantly affected CXR severity (p=0.001), while the CXCL-9 diagnostic model had an AUC of 0.767 (TB vs non-TB) and 0.679 (DS-TB vs DR-TB), with an accuracy of 81.8%. Age was the main predictor of TB status, with a positive trend in CXCL-9.
CXCL-9 levels can differentiate TB from non-TB, but have limitations in distinguishing DS-TB from DR-TB. Combining CXCL 9 with chest X-ray enhances diagnostic accuracy and aids in monitoring TB therapy.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
C-X-C motif chemokine ligand-9,Tuberculosis, Chest X-ray
maximum 3 keywords and no abbreviations, separated by commas
The authors would like to thank the staff of the Pulmonology Department and the Clinical Laboratory for their assistance in data collection. This study received no external funding. The authors declare no conflicts of interest.
317